Işık, A. Et Al. 2023. THE IMPORTANCE OF SOLUBLE PROGRAMMED DEATH LIGAND (sPD-L1) AND CYSTATIN C LEVELS IN DIAGNOSIS ANDTREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMA. EuroMedLab Roma 2023 , (Rome, Italy), 2216.

Işık, A., Muhtaroğlu, S., & Akyol, G., (2023). THE IMPORTANCE OF SOLUBLE PROGRAMMED DEATH LIGAND (sPD-L1) AND CYSTATIN C LEVELS IN DIAGNOSIS ANDTREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMA . EuroMedLab Roma 2023 (pp.2216). Rome, Italy

Işık, AYŞE, SABAHATTİN MUHTAROĞLU, And GÜLŞAH AKYOL. "THE IMPORTANCE OF SOLUBLE PROGRAMMED DEATH LIGAND (sPD-L1) AND CYSTATIN C LEVELS IN DIAGNOSIS ANDTREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMA," EuroMedLab Roma 2023, Rome, Italy, 2023

Işık, AYŞE Et Al. "THE IMPORTANCE OF SOLUBLE PROGRAMMED DEATH LIGAND (sPD-L1) AND CYSTATIN C LEVELS IN DIAGNOSIS ANDTREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMA." EuroMedLab Roma 2023 , Rome, Italy, pp.2216, 2023

Işık, A. Muhtaroğlu, S. And Akyol, G. (2023) . "THE IMPORTANCE OF SOLUBLE PROGRAMMED DEATH LIGAND (sPD-L1) AND CYSTATIN C LEVELS IN DIAGNOSIS ANDTREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMA." EuroMedLab Roma 2023 , Rome, Italy, p.2216.

@conferencepaper{conferencepaper, author={AYŞE Işık Et Al. }, title={THE IMPORTANCE OF SOLUBLE PROGRAMMED DEATH LIGAND (sPD-L1) AND CYSTATIN C LEVELS IN DIAGNOSIS ANDTREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMA}, congress name={EuroMedLab Roma 2023}, city={Rome}, country={Italy}, year={2023}, pages={2216} }